• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Anemia (1706)
Event Date 01/01/2006
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.No kit lot number was provided; therefore, a batch record review could not be conducted.The uvadex lot number was not provided.However, a review of all uvadex lots manufactured since january 2013 was performed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint category anemia.No trends were identified for anemia.From uvadex perspective, there is no evidence to suggest a causal relationship between the drug and the adverse event.This case is serious, unrelated and unexpected to uvadex.This is not reportable from a drug perspective.From a device perspective this event did not cause or contributed to a death or serious injury; and or the system did not cause or contributed to a death or serious injury nor malfunction in a way that would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur.There is no device malfunction.Anemia is listed adverse event in the cellex om section 2-2 (treatment frequency exceeding labeling recommendations may result in anemia).It is unknown how many treatments were given to the patient.Eighteen out of twenty (18/20) patients received iron supplementation.This is considered medical intervention.This case is reportable as an mdr.This assessment is based on information available at the time of the investigation.No product was returned by the customer for investigation; therefore, it could not be determined if this specific product met specification.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).
 
Event Description
An email was received on 8-december-2015 with a link from the (b)(6) in which iron deficiency anemia is associated with extracorporeal photophoresis the 951 iron deficiency anemia associated with extracorporeal photophoresis: a retrospective analysis regulation of iron metabolism program: oral and poster abstracts session: 102.Regulation of iron metabolism: poster i.(b)(6) convention center) alexis k kuhn, pharmd , julianna a merten, pharmd , gabriel t bartoo, pharmd , ross a dierkhising, ms ,jeffrey l.Winters, md , mrinal m patnaik, mbbs , dennis a.Gastineau, md and jill adamski, md, phd department.(b)(6).Abstract: "since its emergence as a novel therapy for cutaneous t-cell lymphoma in 1987, extracorporeal photopheresis (ecp) has gained popularity in the fields of solid organ and stem cell transplantation (perotti et al transfus apher sci 2015).Though ecp is thought to be associated with few adverse effects, we have anecdotally noted that some patients treated with ecp develop iron deficiency anemia.Anemia has been reported in ecp literature at an incidence of anywhere from 0% to 24.5%, however, the etiology of the anemia has not been described (quaglino et al int j dermatol 2013, flowers et al blood 2008, jaksch et al j heart lung transpl 2012, dignan et al bone marrow transpl 2014).We performed a retrospective chart review to further investigate the magnitude of this potential adverse effect.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS, INC.
west chester PA
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 bailey ave.
buffalo NY 14211
Manufacturer Contact
dianna inguanzo
10 north high street
suite 300
west chester, PA 19380
MDR Report Key5323305
MDR Text Key34253645
Report Number2523595-2015-00314
Device Sequence Number1
Product Code LNR
UDI-Device Identifier10705030100009
UDI-Public10705030100009
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/08/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other Health Care Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/08/2015
Initial Date FDA Received12/23/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-